Breast Cancer Research

official impact factor 5.79

Highly Access Email this article to a friend

PARP inhibitors and the treatment of breast cancer: beyond BRCA1/2?

Kristine M Frizzell and W Lee Kraus*

Breast Cancer Research 2009, 11:111 doi:10.1186/bcr2451

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.